GLP-1 medications are not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Market size for GLP-1 receptor agonists is projected to reach USD 7.8 billion by 2036
The HealthRX.com Medical Team Take Kelly Clarkson's public confirmation matters because she represents one of the most common real-world GLP-1 patient profiles: a person with thyroid disease, years of weight cycling, and a medically supervised decision to try pharmacotherapy
Research and legal documents allege that semaglutide, the active ingredient in the popular weight loss drug Wegovy, may cause blindness and vision problems
What is your blood glucose level
The decrease in sex hormones slows down your metabolism, too, so you end up burning about 250300 fewer calories per day